The FDA has approved a generic DuoNeb medication that will be manufactured by Sandoz Pharmaceuticals. However, this generic version is not yet available. It is unknown exactly why generic DuoNeb is not yet available, but it could be because of lawsuits or settlements between the manufacturer of DuoNeb and Sandoz Pharmaceuticals.
Interested in a Discount on DuoNeb?
Enter your email address to see if eMedTV's free DiscountRx service has a program that could help you save on your prescription(s).
Enter Your Email Address
Thank you!Thank you for your interest in DiscountRx from eMedTV. An email has been sent to the address you provided. Please follow the link within that email to see what offers may be available.
DuoNeb® (ipratropium and albuterol solution) is a prescription medication used to treat chronic obstructive pulmonary disease (COPD). DuoNeb contains two separate medications: ipratropium bromide and albuterol sulfate. Ipratropium belongs to a group of medications known as anticholinergics, or antimuscarinics, and albuterol is part of a class of drugs called beta-adrenergic receptor agonists, or beta agonists for short.
DuoNeb is made by Dey, L.P. The U.S. Food and Drug Administration (FDA) has approved a generic version of DuoNeb that will be manufactured by Sandoz Pharmaceuticals. However, this product is not yet available.
This is a difficult question to answer. Even though generic DuoNeb has been approved by the FDA, Sandoz Pharmaceuticals has not yet "launched" the product. This may be the result of ongoing lawsuits or settlements between Sandoz and the manufacturer of DuoNeb. Because these settlements are usually kept confidential, it is difficult to know exactly why Sandoz has not launched their generic DuoNeb product yet. Once Sandoz begins selling it, no other company can sell a similar product for 180 days.
Sometimes, pharmacies make their own medications. Typically, this is done to meet the needs of a specific patient who needs a medication in a different strength or form than what is commercially available. This is known as compounding. Compounding should not be performed in order to provide a "generic" or less expensive version of a commercially available medication. Compounded ipratropium and albuterol nebulizer solutions are not equivalent to DuoNeb and should not be considered generic versions of it.